Transaction #24576 · Form 4 · 0000874015-26-000266
IONIS PHARMACEUTICALS INC · Exercise / conversion · Common Stock
IONIS PHARMACEUTICALS INC · Transacted October 15, 2026 · Filed October 19, 2026
What does this filing report?
An SEC Form 4 filing for IONIS PHARMACEUTICALS INC records an exercise / conversion involving Common Stock on October 15, 2026. The reported quantity was 125. The filing date is October 19, 2026. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- IONIS PHARMACEUTICALS INC
- Company CIK
- 0000874015
- Security type
- Non-derivative
- Acquisition type
- Exercise / conversion · Code M
- Quantity acquired
- 125
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Indirect
- Holdings after transaction
- 443
- Ownership description
- by Son
- SEC acceptance time
- Oct 19, 2026, 9:40 PM EDT
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Swayze Eric ↗
EVP Research
CIK 0001791058
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
The linked listing is identified separately from other current company listings.
Filing footnotes & remarks
- F1
- Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award.
- F2
- The sale was made pursuant to an automatic sale to cover the required tax withholding obligations pursuant to the 2011 Equity Incentive Plan Restricted Stock Unit Agreement and Grant Notice.
- F3
- Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.
- F4
- Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.